Global CRO Strength Covance is a leading global contract research organization within Labcorp, with a strong track record across the full drug development spectrum and relationships with top pharmaceutical and biotech companies. This suggests opportunities to upsell expanded services across nonclinical to clinical development, safety assessment, and translational analytics.

Expansion & Capabilities Recent investments in preclinical oncology facilities and a recognized leadership position indicate capacity to handle larger or more complex programs, including oncology and cell/gene therapy. Sales focus could target sponsors seeking integrated preclinical to early clinical services and specialized oncology assets.

Technologies & Data Heavy tech stack including cloud (Google Cloud Platform), databases (MongoDB), developer tools, and Salesforce, signaling strong data management, analytics, and digital collaboration capabilities. This enables selling advanced data integration, real-time monitoring, and scalable study management solutions.

Awards & Reputation Industry recognition as CRO of the Year and quality awards reinforce credibility with potential clients and regulators. Use this positioning in outreach to reduce sales cycles and build trust with sponsors evaluating CRO partners for risk and quality.

Market Positioning As part of Labcorp with broad coverage and a pedigree of supporting all top 50 prescription drugs, Covance can be pitched as a one-stop shop for sponsors seeking global reach, end-to-end development, and consistent quality across programs, potentially increasing deal size and long‑term partnerships.